Bruker [BRKR] vs Stryker [SYK] Detailed Stock Comparison
Bruker
Stryker
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Bruker wins in 4 metrics, Stryker wins in 15 metrics, with 0 ties. Stryker appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bruker | Stryker | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 66.46 | 49.84 | Stryker |
| Price-to-Book Ratio | 2.91 | 6.77 | Bruker |
| Debt-to-Equity Ratio | 132.75 | 80.83 | Stryker |
| PEG Ratio | 12.75 | 7.21 | Stryker |
| EV/EBITDA | 13.78 | 24.76 | Bruker |
| Profit Margin (TTM) | 2.31% | 12.25% | Stryker |
| Operating Margin (TTM) | 3.61% | 21.95% | Stryker |
| EBITDA Margin (TTM) | 3.61% | 21.95% | Stryker |
| Return on Equity | 4.07% | 14.25% | Stryker |
| Return on Assets (TTM) | 3.55% | 7.74% | Stryker |
| Free Cash Flow (TTM) | $136.00M | $3.49B | Stryker |
| Dividend Yield | N/A | 0.88% | N/A |
| 1-Year Return | -44.33% | 4.11% | Stryker |
| Price-to-Sales Ratio (TTM) | 1.52 | 6.02 | Bruker |
| Enterprise Value | $7.69B | $158.14B | Stryker |
| EV/Revenue Ratio | 2.23 | 6.64 | Bruker |
| Gross Profit Margin (TTM) | 44.88% | 63.78% | Stryker |
| Revenue per Share (TTM) | $23 | $62 | Stryker |
| Earnings per Share (Diluted) | $0.52 | $7.53 | Stryker |
| Beta (Stock Volatility) | 1.20 | 0.95 | Stryker |
Bruker vs Stryker Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bruker | -1.81% | 3.16% | 15.23% | -14.70% | -12.77% | -38.90% |
| Stryker | -1.51% | 1.04% | -5.74% | -5.57% | 1.99% | 3.20% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bruker | -44.33% | -34.59% | -14.84% | 99.06% | 140.98% | 687.94% |
| Stryker | 4.11% | 77.02% | 65.23% | 270.09% | 654.89% | 696.81% |
News Based Sentiment: Bruker vs Stryker
Bruker
News based Sentiment: MIXED
October presented a mixed bag for Bruker, with an earnings miss and lowered guidance countered by new orders, a strategic merger, and continued institutional investment. The conflicting signals create uncertainty, making it a significant but not overwhelmingly positive or negative month for the company.
Stryker
News based Sentiment: MIXED
October was a mixed month for Stryker, with strong financial results and strategic partnerships offset by stock price declines and insider selling. While the company reaffirmed its guidance and continues to invest in innovation, the conflicting signals suggest a cautious outlook for investors, making it a significant month to assess the company's trajectory.
Performance & Financial Health Analysis: Bruker vs Stryker
| Metric | BRKR | SYK |
|---|---|---|
| Market Information | ||
| Market Cap | $5.24B | $143.48B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 3,829,870 | 1,634,475 |
| 90 Day Avg. Volume | 4,691,247 | 1,322,345 |
| Last Close | $35.28 | $364.60 |
| 52 Week Range | $28.53 - $65.25 | $329.16 - $406.19 |
| % from 52W High | -45.93% | -10.24% |
| All-Time High | $94.86 (Mar 18, 2024) | $406.19 (Jan 27, 2025) |
| % from All-Time High | -62.81% | -10.24% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.00% | 0.11% |
| Quarterly Earnings Growth | 0.00% | 0.07% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.12% |
| Operating Margin (TTM) | 0.04% | 0.22% |
| Return on Equity (TTM) | 0.04% | 0.14% |
| Debt to Equity (MRQ) | 132.75 | 80.83 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $11.89 | $55.43 |
| Cash per Share (MRQ) | $0.65 | $6.45 |
| Operating Cash Flow (TTM) | $165.90M | $4.77B |
| Levered Free Cash Flow (TTM) | $223.20M | $3.49B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.88% |
| Last 12-Month Dividend | N/A | $3.28 |
Valuation & Enterprise Metrics Analysis: Bruker vs Stryker
| Metric | BRKR | SYK |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 66.46 | 49.84 |
| Forward P/E | 12.75 | 27.74 |
| PEG Ratio | 12.75 | 7.21 |
| Price to Sales (TTM) | 1.52 | 6.02 |
| Price to Book (MRQ) | 2.91 | 6.77 |
| Market Capitalization | ||
| Market Capitalization | $5.24B | $143.48B |
| Enterprise Value | $7.69B | $158.14B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.23 | 6.64 |
| Enterprise to EBITDA | 13.78 | 24.76 |
| Risk & Other Metrics | ||
| Beta | 1.20 | 0.95 |
| Book Value per Share (MRQ) | $11.89 | $55.43 |
Financial Statements Comparison: Bruker vs Stryker
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BRKR | SYK |
|---|---|---|
| Revenue/Sales | $801.40M | $6.02B |
| Cost of Goods Sold | $410.20M | $2.18B |
| Gross Profit | $391.20M | $3.84B |
| Research & Development | $97.10M | $407.00M |
| Operating Income (EBIT) | $65.70M | $1.17B |
| EBITDA | $118.60M | $1.52B |
| Pre-Tax Income | $25.10M | $1.02B |
| Income Tax | $8.70M | $132.00M |
| Net Income (Profit) | $16.80M | $884.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BRKR | SYK |
|---|---|---|
| Cash & Equivalents | $184.20M | $2.32B |
| Total Current Assets | $2.11B | $13.02B |
| Total Current Liabilities | $1.34B | $7.93B |
| Long-Term Debt | $2.08B | $14.38B |
| Total Shareholders Equity | $1.85B | $20.93B |
| Retained Earnings | $2.42B | $18.86B |
| Property, Plant & Equipment | N/A | $1.67B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BRKR | SYK |
|---|---|---|
| Operating Cash Flow | $55.70M | $719.00M |
| Capital Expenditures | $-26.00M | $-123.00M |
| Free Cash Flow | $39.00M | $127.00M |
| Debt Repayment | $-175.60M | N/A |
| Common Stock Repurchase | $-10.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BRKR | SYK |
|---|---|---|
| Shares Short | 12.19M | 4.61M |
| Short Ratio | 2.77 | 4.52 |
| Short % of Float | 0.17% | 0.01% |
| Average Daily Volume (10 Day) | 3,829,870 | 1,634,475 |
| Average Daily Volume (90 Day) | 4,691,247 | 1,322,345 |
| Shares Outstanding | 151.68M | 381.40M |
| Float Shares | 103.14M | 344.60M |
| % Held by Insiders | 0.32% | 0.05% |
| % Held by Institutions | 0.85% | 0.82% |
Dividend Analysis & Yield Comparison: Bruker vs Stryker
| Metric | BRKR | SYK |
|---|---|---|
| Last 12-Month Dividend | N/A | $3.28 |
| Last 12-Month Dividend Yield | N/A | 0.88% |
| 3-Year Avg Annual Dividend | N/A | $3.09 |
| 3-Year Avg Dividend Yield | N/A | 0.27% |
| 3-Year Total Dividends | N/A | $9.26 |
| Ex-Dividend Date | N/A | Mar 31, 2025 |